Cita APA (7a ed.)

Odintsova, S. V., Sviridenko, M. A., Cheremnykh, A. O., Filippova, E. A., Urtenova, M. A., & Orlov, S. V. (2020). Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma. IP Habib O.N.

Cita Chicago Style (17a ed.)

Odintsova, Svetlana V., Mariia A. Sviridenko, Antonina O. Cheremnykh, Elena A. Filippova, Magaripa A. Urtenova, y Sergei V. Orlov. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.

Cita MLA (8a ed.)

Odintsova, Svetlana V., et al. Clinical Case of Long-term Use of Osimertinib in the Treatment of EGFR Mutation-positive Lung Adenocarcinoma. IP Habib O.N, 2020.